Featuring: Ali Shilatifard, PhD
For three decades, Ali Shilatifard, PhD, has dedicated his career to revealing the causes of childhood leukemia, providing detailed molecular insight into the role of epigenetics in cancer. He hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
This podcast was originally release via the Feinberg School of Medicine News Center in June 2019.
Ali Shilatifard, PhD
Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.